Transgenic GroupTSE:2342 +1.89%60 Gross Margin % is 17.41% as of Mar. 2026, which is 3% below its 10-year median of 17.96. GuruFocus rates TSE:2342 with a GF Score™ of 60/100 and a GF Value™ of 円257.46 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 732 Biotechnology companies, Transgenic Group ranks worse than 85.66% on this metric.
Transgenic Group Inc gross margin has been in long-term decline. The average rate of decline per year is -9.2%.
The historical rank and industry rank for Transgenic Group's Gross Margin % or its related term are showing as below:
TSE:2342'
s Gross Margin % Range Over the Past 10 Years
Min: 16.11 Med: 17.96 Max: 32.52
Current: 18.47
During the past 13 years, the highestGross Margin % of Transgenic Group was 32.52%. The lowest was 16.11%. And the median was 17.96%.
TSE:2342's Gross Margin % is ranked worse than 85.66% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs TSE:2342: 18.47
Transgenic Group had a gross margin of 17.41% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Transgenic Group was -9.20% per year.
Transgenic Group (TSE:2342) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Transgenic Group had a gross margin of 17.41% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Transgenic Group Gross Margin % Related Terms
Transgenic Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Transgenic Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2342 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Transgenic Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transgenic Group Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Transgenic Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Transgenic Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Transgenic Group (TSE:2342) has a Gross Margin % of 17.41% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Transgenic Group and its competitors. This is near median its historical median of 17.96. Over the past decade, Transgenic Group's Gross Margin % has ranged from 16.11 to 32.52. According to the industry distribution chart, Transgenic Group ranks #627 out of 732 companies in the Biotechnology industry, placing it in the top 85.7%.
Is Transgenic Group's Gross Margin % too high?
Transgenic Group's current Gross Margin % of 17.41% is near median its 10-year median of 17.96. Over the past 10 years, this metric has ranged from a low of 16.11 to a high of 32.52. The Biotechnology industry median Gross Margin % is 60.91. Transgenic Group's value of 17.41% is 71.4% below this industry median. Based on the distribution chart, Transgenic Group ranks #627 out of 732 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Transgenic Group has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Transgenic Group ranks #627 out of 732 companies for Gross Margin %. This places Transgenic Group in the lower half of its industry. The industry median Gross Margin % is 60.91. Transgenic Group's value of 17.41% is 71.4% below this benchmark. Historically, Transgenic Group's own Gross Margin % has ranged from 16.11 to 32.52 over the past decade. While the company's 10-year median is 17.96 vs. the industry median of 60.91, Transgenic Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Transgenic Group's current Gross Margin % of 17.41% is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Transgenic Group and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Transgenic Group's current Gross Margin % is 17.41%, which is near median its own 10-year median of 17.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.46, compared to a current price of 円216.00 — trading 16.1% below its estimated fair value. The current Gross Margin % is 17.41%, which is near median its 10-year median of 17.96 and 71.4% below the Biotechnology industry median of 60.91. Transgenic Group's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Gross Margin % is 17.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transgenic Group (TSE:2342) Overvalued in 2026?
Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued.
The current stock price of 円216.00 is trading 16.1% below its estimated GF Value™ of 円257.46.
GuruFocus considers Transgenic Group to be Modestly Undervalued.
Key valuation signals for TSE:2342:
Gross Margin %: 17.41% (near median its 10-year median of 17.96)
GF Value™: 円257.46 vs. price of 円216.00 (16.1% below fair value)
Industry Position: 71.4% below the Biotechnology median (#627 of 732)
No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
60GF Score
Get the complete analysis for TSE:2342
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2342 has been successfully added to your 
